Gainers

  • AMN Healthcare Services (NYSE:AMN) stock increased by 25.6% to $28.2 during Friday's regular session. The market value of their outstanding shares is at $867.8 million. The company's, Q1 earnings came out yesterday.
  • Inovio Pharmaceuticals (NASDAQ:INO) stock rose 25.28% to $1.72. The company's market cap stands at $111.7 million.
  • Maravai LifeSciences (NASDAQ:MRVI) stock moved upwards by 23.22% to $4.86. The market value of their outstanding shares is at $571.3 million. The company's, Q1 earnings came out yesterday.
  • Traws Pharma (NASDAQ:TRAW) stock moved upwards by 22.35% to $2.08. The market value of their outstanding shares is at $17.2 million.
  • Co-Diagnostics (NASDAQ:CODX) shares rose 20.72% to $2.33. The company's market cap stands at $4.0 million.
  • PTC Therapeutics (NASDAQ:PTCT) shares increased by 20.31% to $77.59. The market value of their outstanding shares is at $5.3 billion. As per the press release, Q1 earnings came out yesterday.

Losers

  • AIM ImmunoTech (AMEX:AIM) stock decreased by 35.1% to $0.36 during Friday's regular session. The market value of their outstanding shares is at $2.2 million.
  • Artivion (NYSE:AORT) stock decreased by 26.6% to $26.0. The company's market cap stands at $1.6 billion. As per the press release, Q1 earnings came out yesterday.
  • Sensus Healthcare (NASDAQ:SRTS) shares declined by 26.53% to $3.02. The market value of their outstanding shares is at $67.6 million. As per the news, the Q1 earnings report came out yesterday.
  • Akanda (NASDAQ:AKAN) shares declined by 25.68% to $27.64. The company's market cap stands at $19.8 million.
  • Amphastar Pharma (NASDAQ:AMPH) stock fell 23.6% to $18.36. The market value of their outstanding shares is at $1.0 billion. As per the press release, Q1 earnings came out yesterday.
  • Outset Medical (NASDAQ:OM) shares fell 20.3% to $3.73. The company's market cap stands at $86.7 million. As per the press release, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.